Pa is difficult to manage, particularly in people with cystic fibrosis and advanced lung disease1
The Cystic Fibrosis Foundation’s Pulmonary Guidelines
For individuals with CF, 6 years of age and older, with moderate to severe lung disease and Pa persistently present in cultures of the airways, the CF Foundation strongly recommends the chronic use of inhaled tobramycin to improve lung function and reduce exacerbations.2
Treatment Goals for Pa
- • Treat for first and intermittently positive Pa cultures early to delay or avoid chronic Pa infection1
- • For patients who are persistently positive for Pa, especially those with loss of lung function, continue to treat with antibiotics2
Watch a video on Pa treatment in CF
Dr Konstan received a fee for his service from Viatris Specialty LLC for his participation in this program.
Pa: Pseudomonas aeruginosa.
REFERENCES
- Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Ann Am Thorac Soc. 2014;11(10):1640-1650. doi:10.1513/AnnalsATS.201404-166OC.
- Mogayzel PJ Jr, Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187(7):680-689. doi:10.1164/rccm.201207-1160e.